Internal Medicine
RSSArticles
-
Internal Medicine Alert - Full October 29, 2009 Issue in PDF
-
Pharmacology Update: Asenapine Sublingual Tablets (Saphris®
The ninth atypical antipsychotic agent has been approved by the FDA. Asenapine is somewhat unique in the class with different receptor binding than risperidone and olanzapine. -
Pharmacology Watch: SSRIs and Pregnancy: Increase in Septal Heart Defects
In this issue: Depression and pregnancy, new vaccine recommendations from the CDC, cortico-steroids and/or antivirals for Bell's palsy, rasagiline and Parkinson's disease, and FDA Actions. -
Chronic Fatigue Syndrome — Could a "Stealth Virus" Be Lurking?
It has been known for years that patients with chronic fatigue syndrome (CFS) have a defect in a major antiviral pathway, the 2-5A/RNase L pathway. The RNaseL produces non-specific viral cleavage and, thus, protects us from many viral infections (innate immunity). -
Infectious Disease Alert November 2009 Issue in PDF
-
Clinical Briefs in Primary Care supplement
-
Updates By Carol A. Kemper, MD, FACP
Data showing an increased risk of MRSA and C. difficile colonization on the footpads and coats of dogs and cats used for pet therapy in hospitals was discussed briefly in May 2009. -
Critical Care Alert November 2009 Issue in PDF
-
Clinical Briefs in Primary Care supplement
-
Pharmacology Watch: SSRIs and Pregnancy: Increase in Septal Heart Defects
In this issue: Depression and pregnancy, new vaccine recommendations from the CDC, cortico-steroids and/or antivirals for Bell's palsy, rasagiline and Parkinson's disease, and FDA Actions.